Arenicin (2-21) [V3R; Y4,6R; A5Y; R8L]
General Information
DCTPep ID DCTPep03839
Peptide Name Arenicin (2-21) [V3R; Y4,6R; A5Y; R8L]
Sequence WCRRYRVLVRGVLVRYRRCW
Sequence Length 20
UniProt ID Q5SC60
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys2<--->Cys19
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C122H195N43O23S2
Absent amino acids ADEFHIKMNPQST
Theoretical pI 11.62
Acidic residues 0
Basic residues 7
Polar residues 5
Molecular weight (Average) 2696.28
Molecular weight (Monoisotopic) 2694.49
Common amino acids R
Net charge 7
Instability index (II) 49.92
Aliphatic index 97.00
Grand average of hydropathicity (GRAVY) -0.345
Half Life
2.8 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 14105
Abs 0.1% (=1 g/l) 5.231, assuming all pairs of Cys residues form cystines
Ext. coefficient 13980
Abs 0.1% (=1 g/l) 5.185, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31234579
Title Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 13507